Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: Time to modify the current American Joint Committee on Cancer staging system

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4654-4661

  Yi, Min ^a   Mittendorf, Elizabeth A ^a   Cormier, Janice N ^a   Buchholz, Thomas A ^a   Bilimoria, Karl ^a   Sahin, Aysegul A ^a   Hortobagyi, Gabriel N ^a   Gonzalez Angulo, Ana Maria ^a   Luo, Sheng ^b   Buzdar, Aman U ^a   Crow, Jaime R ^a   Kuerer, Henry M ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BOOTSTRAPPING; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 83355174080     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.3174     Document Type: Article

References (39)

1. Edge SB, Byrd DR, Compton CC: AJCC Cancer Staging Manual (ed 7). Chicago, IL, Springer, 2009
2. Jeruss JS, Mittendorf EA, Tucker SL, et al: Staging of breast cancer in the neoadjuvant setting. Cancer Res 68:6477-6481, 2008
3. Rakha EA, Reis-Filho JS, Baehner F, et al: Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Res 12:207, 2010
4. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer - Experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
5. Calza S, Hall P, Auer G, et al: Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 8:R34, 2006
6. Harigopal M, Barlow WE, Tedeschi G, et al: Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome. Am J Pathol 176:1639-1647, 2010
7. Ross JS: Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Adv Anat Pathol 16:204-215, 2009
8. Wang Y, Klijn JG, Zhang Y, et al: Geneexpression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671-679, 2005 (Pubitemid 40260888)
9. Jeruss JS, Mittendorf EA, Tucker SL, et al: Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26:246-252, 2008
10. Mittendorf EA, Jeruss JS, Tucker SL, et al: Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 29:1956-1962, 2011
11. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659-1672, 2005 (Pubitemid 41464705)
12. Romond EH, Perez EA, Bryant J, et al: Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673-1684, 2005 (Pubitemid 41464706)
13. Nguyen PL, Taghian AG, Katz MS, et al: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373-2378, 2008
14. Harrell FE Jr, Califf RM, Pryor DB, et al: Evaluating the yield of medical tests. JAMA 247:2543-2546, 1982 (Pubitemid 12155954)
15. Gonen M, Heller G: Concordance probability and discriminatory power in proportional hazards regression. Biometrika 92:965-970, 2005 (Pubitemid 41681247)
16. Akaike H: New look at statistical-model identification. IEEE Trans Automat Contr 19:716-723, 1974
17. Leggett MD, Chen SL, Schneider PD, et al: Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol 15:2493-2499, 2008
18. Martinez SR, Robbins AS, Meyers FJ, et al: Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer 112:1162-1168, 2008 (Pubitemid 351304603)
19. Chen SL, Martinez SR: The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence. Am J Surg 196:495-499, 2008
20. Park YH, Lee SJ, Cho EY, et al: Clinical relevance of TNM staging system according to breast cancer subtypes. Ann Oncol 22:1554-1560, 2011
21. Veronesi U, Zurrida S, Viale G, et al: Rethinking TNM: A breast cancer classification to guide treatment and facilitate research. Breast J 15:291-295, 2009
22. Baak JP, Van Dop H, Kurver PH, et al: The value of morphometry to classic prognosticators in breast cancer. Cancer 56:374-382, 1985 (Pubitemid 15031663)
23. Chevallier B, Mosseri V, Dauce JP, et al: A prognostic score in histological node negative breast cancer. Br J Cancer 61:436-440, 1990 (Pubitemid 20106022)
24. D'Eredita G, Giardina C, Martellotta M, et al: Prognostic factors in breast cancer: The predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 37:591-596, 2001 (Pubitemid 32261016)
25. Rakha EA, El-Sayed ME, Lee AH, et al: Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol 26:3153-3158, 2008
26. Frkovic-Grazio S, Bracko M: Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. J Clin Pathol 55:88-92, 2002 (Pubitemid 34123906)
27. Lundin J, Lundin M, Holli K, et al: Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: Results from a nationwide study. J Clin Oncol 19:28-36, 2001
28. Wasif N, Ko CY, Farrell J, et al: Impact of tumor grade on prognosis in pancreatic cancer: Should we include grade in AJCC staging? Ann Surg Oncol 17:2312-2320, 2010
29. Rakha EA, El-Sayed ME, Menon S, et al: Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 111:121-127, 2008 (Pubitemid 352009237)
30. Mohammed RA, Martin SG, Mahmmod AM, et al: Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: Findings from a large case series with long-term follow-up. J Pathol 223:358-365, 2011
31. Brenton JD, Carey LA, Ahmed AA, et al: Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? J Clin Oncol 23:7350-7360, 2005 (Pubitemid 46202348)
32. Perou CM, Sørlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
33. Sørlie T, Perou CM, Tibshirani R, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874, 2001 (Pubitemid 32878711)
34. Rakha EA, El-Sayed ME, Green AR, et al: Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 25:4772-4778, 2007 (Pubitemid 350086480)
35. Brennan MF, Kattan MW, Klimstra D, et al: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293-298, 2004 (Pubitemid 38963021)
36. Kattan MW, Karpeh MS, Mazumdar M, et al: Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21:3647-3650, 2003 (Pubitemid 46594058)
37. Kattan MW, Wheeler TM, Scardino PT: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17:1499-1507, 1999 (Pubitemid 29220858)
38. Stephenson AJ, Scardino PT, Eastham JA, et al: Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23:7005-7012, 2005
39. Weiser MR, Landmann RG, Kattan MW, et al: Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 26:380-385, 2008 (Pubitemid 351171688)